Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Davidson

Showing results (221-230 of 285) with videos related to

Pageof 29
Sort By:
Breast Cancer Research and Treatment|April 17, 2013
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancerMichelle A Rudek, Roisin M Connolly, Janelle M Hoskins, et al.
Cancer|June 8, 2013
Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831Alvaro Moreno-Aspitia, David W Hillman, Stephen H Dyar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastasesJulie M Wu, Mary Jo Fackler, Marc K Halushka, et al.
NPJ Breast Cancer|July 25, 2024
Cook and Move for Your Life, an eHealth intervention for women with breast cancerHeather Greenlee, Eileen Rillamas-Sun, Rachel L Yung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2019
Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline UpdateKala Visvanathan, Carol J Fabian, Elissa Bantug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathwayKideok Jin, Xiangjun Kong, Tariq Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trialEdith A Perez, Amylou C Dueck, Ann E McCullough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199Sylvia Adams, Robert J Gray, Sandra Demaria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2016
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart FailureBryan P Schneider, Fei Shen, Laura Gardner, et al.
Pageof 29

Showing results (221-230 of 285) with videos related to

Sort By:
Pageof 29
Breast Cancer Research and Treatment|April 17, 2013
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancerMichelle A Rudek, Roisin M Connolly, Janelle M Hoskins, et al.
Cancer|June 8, 2013
Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831Alvaro Moreno-Aspitia, David W Hillman, Stephen H Dyar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastasesJulie M Wu, Mary Jo Fackler, Marc K Halushka, et al.
NPJ Breast Cancer|July 25, 2024
Cook and Move for Your Life, an eHealth intervention for women with breast cancerHeather Greenlee, Eileen Rillamas-Sun, Rachel L Yung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2019
Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline UpdateKala Visvanathan, Carol J Fabian, Elissa Bantug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathwayKideok Jin, Xiangjun Kong, Tariq Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trialEdith A Perez, Amylou C Dueck, Ann E McCullough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199Sylvia Adams, Robert J Gray, Sandra Demaria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2016
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart FailureBryan P Schneider, Fei Shen, Laura Gardner, et al.
Pageof 29